HTG Molecular Diagnostics, Inc. Proceeds from Issuance Initial Public Offering
HTG Molecular Diagnostics, Inc. reported Proceeds from Issuance Initial Public Offering of $9.06 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2023-03-30
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for the quarter ending 2018-12-31 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for the quarter ending 2018-09-30 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for the quarter ending 2018-06-30 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for the quarter ending 2018-03-31 was $37.72M.
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for fiscal 2022 was $9.06M.
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for fiscal 2021 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for fiscal 2018 was $37.72M.
- HTG Molecular Diagnostics, Inc. proceeds from issuance initial public offering for fiscal 2017 was -$231.48K.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 3 month as first filed | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 6 month as first filed | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 9 month as first filed | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $9.06M 10-K · filed 2023-03-30 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $0.00 derived: sum of 2 quarters · filed 2020-03-25 | $0.00 derived: sum of 3 quarters · filed 2020-03-25 | $37.72M 10-K · filed 2020-03-25 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $37.72M 10-Q · filed 2019-11-12 | $37.93M 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $37.72M 10-Q · filed 2019-08-06 | $37.93M 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | $37.72M 10-Q · filed 2019-05-09 | $37.93M 10-Q · filed 2018-05-10 | |||||
| 2017-12-31 | -$231.48K 10-K · filed 2019-03-07 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $0.00 derived: sum of 2 quarters · filed 2017-03-23 | $47.65M 10-K · filed 2017-03-23 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $47.65M 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $47.65M 10-Q · filed 2016-08-09 |